Life insurers in India are seeking regulatory approval from Irdai to invest in gold ETFs, driven by their impressive returns exceeding 30% in the last year. This move aims to diversify portfolios within ULIPs and hedge against market volatility, as traditional assets offer lower returns.
Laurus Labs shares climb 4% after Q2 profit zooms 126% YoY
Laurus Labs shares rose 3.79% to Rs 2,329 after the pharmaceutical company reported strong Q2FY27 results. Revenue increased 33% year-on-year to Rs 2,206 crore, while